Page 5 - Hikma - Oncology booklet
P. 5
Indication
Adricin, USP is indicated as a component of multi-agent
adjuvant chemotherapy for treatment of women with axillary
lymph node involvement following resection of primary breast
cancer.
Associated Conditions
01 Acute lymphoblastic 02 Acute myeloblastic
leukemia leukemia
Hodgkin and Non- Metastatic ovarian
03 Hodgkin lymphoma 04 & breast cancer
05 Metastatic 06 Metastatic
wilms' tumor neuroblastoma
07 Metastatic soft 08 Metastatic bone
tissue sarcoma sarcomas
Metastatic Transitional cell
09 bronchogenic carcinoma 10 bladder carcinoma
11 Metastatic thyroid 12 Metastatic gastric
carcinoma carcinoma
4
